NURS 5434 FNP Final Exam PREP
NURS 5434 FNP FINAL EXAM PREP LATEST 2025/2026 ACTUAL
EXAM TEST BANK COMPLETE 180 QUESTIONS AND CORRECT
ANSWERS WITH DETAILED RATIONALES GRADED A+
GUARANTEED PASS- ACE YOUR EXAM
A 65 year old man comes to a primary care facility. He states that it has been 10
years since his last Tetanus shot and he is excited about seeing his newborn
grandchild, he should be offered and immunization with:
A. Tdap
B. Prevnar 23
C. Hepatitis B
D. HPV
A. Tdap
Rationale:
Adults should receive a Tdap booster once in adulthood if they have not previously
received it, followed by Td boosters every ten years. Tdap protects against tetanus,
diphtheria, and pertussis, and pertussis is particularly dangerous for newborn
infants who are too young to be fully vaccinated. Because this patient plans to
have close contact with a newborn grandchild, administering Tdap provides an
opportunity to protect both the patient and the infant from potential transmission
of pertussis.
Which of the following is Secondary prevention? SATA
A. Influenza vaccine
B. COVID-19 booster
C. Mammogram
D. Antibiotics for an STI
1|Page
, NURS 5434 FNP Final Exam PREP
E. Pap smear
F. Colonoscopy
C. Mammogram
E. Pap smear
F. Colonoscopy
Rationale:
Secondary prevention focuses on early detection and treatment of disease before
symptoms develop, with the goal of reducing morbidity and preventing
progression. Screening tests such as mammograms, Pap smears, and
colonoscopies identify disease in its early stages or detect precancerous changes.
In contrast, vaccines are examples of primary prevention because they prevent
disease from occurring, and antibiotic treatment for an STI represents tertiary or
treatment-based care rather than early detection.
Age range for HPV vaccine
9-45 years old
Rationale:
The HPV vaccine is approved for individuals between ages 9 and 45 to protect
against high-risk strains of the human papillomavirus associated with cervical,
anal, oropharyngeal, and other cancers. Vaccination is most effective when given
before exposure to HPV, which is why routine vaccination is recommended
beginning at ages 11–12, though it can start as early as age 9. Adults up to age 45
may also benefit, particularly if they have not previously been vaccinated or
exposed to certain HPV strains.
Polly is 66 years old. She smokes and enjoys going on walks to the park twice a
week. Which of the following vaccines would you recommend for her? SATA
A. HPV
B. Meningococcal Vaccine
2|Page
, NURS 5434 FNP Final Exam PREP
C. Prevnar 13 (PCV13)
D. Hepatitis B
E. Pneumovax 23 (PPSV23)
C. Prevnar 13 (PCV13)
E. Pneumovax 23 (PPSV23)
Rationale:
Adults age 65 and older are at increased risk of severe illness from pneumococcal
infections such as pneumonia, meningitis, and bacteremia. For this population,
pneumococcal vaccination is recommended to provide protection against multiple
pneumococcal serotypes. PCV13 (a conjugate vaccine) helps stimulate a stronger
immune response, while PPSV23 covers additional pneumococcal strains. Because
smoking also increases susceptibility to respiratory infections, pneumococcal
vaccination is especially important for individuals like Polly.
Polly is 66 years old. She smokes and enjoys going on walks to the park twice a
week. She tells you that she has never gotten the pneumococcal shot. Which of
the following vaccines would you recommend for her TODAY?
A. Prevnar 20 (PCV 20)
B. Meningococcal Vaccine
C. Prevnar 13 (PCV13)
D. Hepatitis B
E. Pneumovax 23 (PPSV23)
A. Prevnar 20 (PCV 20)
Rationale:
PCV20 (Prevnar 20) is a newer pneumococcal conjugate vaccine that protects
against 20 pneumococcal serotypes and can simplify vaccination schedules. For
adults aged 65 or older who have never received a pneumococcal vaccine, PCV20
alone can provide broad protection without requiring additional conjugate
3|Page
, NURS 5434 FNP Final Exam PREP
vaccines at the same visit. It stimulates a strong immune response and offers
expanded coverage compared with earlier formulations.
Polly is 66 years old. She smokes and enjoys going on walks to the park twice a
week. She tells you that she has never gotten the pneumococcal shot. You give
PCV 20 today, what do you give 1 year from now?
A. Prevnar 20 booster (PCV 20)
B. Meningococcal Vaccine
C. Prevnar 13 (PCV13)
D. Hepatitis B
E. Pneumovax 23 (PPSV23)
E. Pneumovax 23 (PPSV23)
Rationale:
Following pneumococcal vaccination schedules, patients may receive PPSV23 after
a conjugate vaccine to expand protection against additional pneumococcal strains.
PPSV23 includes protection against 23 serotypes of Streptococcus pneumoniae.
The interval allows the immune system to respond appropriately to the conjugate
vaccine first and then broaden coverage through the polysaccharide vaccine.
All of the following patients received the pneumococcal vaccine 5 years ago.
Who's is the best candidate for the second dose AntiPneumococcal vaccination at
this time.
A. A 66 year old male on dialysis
B. A 70 year old female with diabetes
C. A 65 year old male who is sexually active and has multiple partners
D. A 66 year old woman with COPD
D. A 66 year old woman with COPD
4|Page
NURS 5434 FNP FINAL EXAM PREP LATEST 2025/2026 ACTUAL
EXAM TEST BANK COMPLETE 180 QUESTIONS AND CORRECT
ANSWERS WITH DETAILED RATIONALES GRADED A+
GUARANTEED PASS- ACE YOUR EXAM
A 65 year old man comes to a primary care facility. He states that it has been 10
years since his last Tetanus shot and he is excited about seeing his newborn
grandchild, he should be offered and immunization with:
A. Tdap
B. Prevnar 23
C. Hepatitis B
D. HPV
A. Tdap
Rationale:
Adults should receive a Tdap booster once in adulthood if they have not previously
received it, followed by Td boosters every ten years. Tdap protects against tetanus,
diphtheria, and pertussis, and pertussis is particularly dangerous for newborn
infants who are too young to be fully vaccinated. Because this patient plans to
have close contact with a newborn grandchild, administering Tdap provides an
opportunity to protect both the patient and the infant from potential transmission
of pertussis.
Which of the following is Secondary prevention? SATA
A. Influenza vaccine
B. COVID-19 booster
C. Mammogram
D. Antibiotics for an STI
1|Page
, NURS 5434 FNP Final Exam PREP
E. Pap smear
F. Colonoscopy
C. Mammogram
E. Pap smear
F. Colonoscopy
Rationale:
Secondary prevention focuses on early detection and treatment of disease before
symptoms develop, with the goal of reducing morbidity and preventing
progression. Screening tests such as mammograms, Pap smears, and
colonoscopies identify disease in its early stages or detect precancerous changes.
In contrast, vaccines are examples of primary prevention because they prevent
disease from occurring, and antibiotic treatment for an STI represents tertiary or
treatment-based care rather than early detection.
Age range for HPV vaccine
9-45 years old
Rationale:
The HPV vaccine is approved for individuals between ages 9 and 45 to protect
against high-risk strains of the human papillomavirus associated with cervical,
anal, oropharyngeal, and other cancers. Vaccination is most effective when given
before exposure to HPV, which is why routine vaccination is recommended
beginning at ages 11–12, though it can start as early as age 9. Adults up to age 45
may also benefit, particularly if they have not previously been vaccinated or
exposed to certain HPV strains.
Polly is 66 years old. She smokes and enjoys going on walks to the park twice a
week. Which of the following vaccines would you recommend for her? SATA
A. HPV
B. Meningococcal Vaccine
2|Page
, NURS 5434 FNP Final Exam PREP
C. Prevnar 13 (PCV13)
D. Hepatitis B
E. Pneumovax 23 (PPSV23)
C. Prevnar 13 (PCV13)
E. Pneumovax 23 (PPSV23)
Rationale:
Adults age 65 and older are at increased risk of severe illness from pneumococcal
infections such as pneumonia, meningitis, and bacteremia. For this population,
pneumococcal vaccination is recommended to provide protection against multiple
pneumococcal serotypes. PCV13 (a conjugate vaccine) helps stimulate a stronger
immune response, while PPSV23 covers additional pneumococcal strains. Because
smoking also increases susceptibility to respiratory infections, pneumococcal
vaccination is especially important for individuals like Polly.
Polly is 66 years old. She smokes and enjoys going on walks to the park twice a
week. She tells you that she has never gotten the pneumococcal shot. Which of
the following vaccines would you recommend for her TODAY?
A. Prevnar 20 (PCV 20)
B. Meningococcal Vaccine
C. Prevnar 13 (PCV13)
D. Hepatitis B
E. Pneumovax 23 (PPSV23)
A. Prevnar 20 (PCV 20)
Rationale:
PCV20 (Prevnar 20) is a newer pneumococcal conjugate vaccine that protects
against 20 pneumococcal serotypes and can simplify vaccination schedules. For
adults aged 65 or older who have never received a pneumococcal vaccine, PCV20
alone can provide broad protection without requiring additional conjugate
3|Page
, NURS 5434 FNP Final Exam PREP
vaccines at the same visit. It stimulates a strong immune response and offers
expanded coverage compared with earlier formulations.
Polly is 66 years old. She smokes and enjoys going on walks to the park twice a
week. She tells you that she has never gotten the pneumococcal shot. You give
PCV 20 today, what do you give 1 year from now?
A. Prevnar 20 booster (PCV 20)
B. Meningococcal Vaccine
C. Prevnar 13 (PCV13)
D. Hepatitis B
E. Pneumovax 23 (PPSV23)
E. Pneumovax 23 (PPSV23)
Rationale:
Following pneumococcal vaccination schedules, patients may receive PPSV23 after
a conjugate vaccine to expand protection against additional pneumococcal strains.
PPSV23 includes protection against 23 serotypes of Streptococcus pneumoniae.
The interval allows the immune system to respond appropriately to the conjugate
vaccine first and then broaden coverage through the polysaccharide vaccine.
All of the following patients received the pneumococcal vaccine 5 years ago.
Who's is the best candidate for the second dose AntiPneumococcal vaccination at
this time.
A. A 66 year old male on dialysis
B. A 70 year old female with diabetes
C. A 65 year old male who is sexually active and has multiple partners
D. A 66 year old woman with COPD
D. A 66 year old woman with COPD
4|Page
